The Federal Center for Animal Health Protection (VNIITZH), part of the Russian Agricultural Surveillance Agency, has made significant strides in animal health by exporting more than 224 million doses of animal vaccines since the beginning of 2025. This achievement highlights the organization's pivotal role in ensuring global animal health while also generating substantial economic benefits for the country.
The immunobiological preparations exported by VNIITZH are aimed at preventing various diseases affecting livestock and poultry, including avian influenza, swine influenza, and other poultry diseases. These vaccines have found a market in 11 countries, showcasing the demand for Russian-made veterinary products.
According to VNIITZH officials, the countries that have received these vital vaccines include Saudi Arabia, Pakistan, Morocco, Kuwait, Iran, Egypt, Bangladesh, Kazakhstan, Afghanistan, Belarus, and Armenia. This diverse list underscores the global trust in the safety and effectiveness of Russian veterinary vaccines, particularly in regions where animal health is crucial for economic stability.
The data provided by VNIITZH indicates that in 2024, the center produced an astounding 13 billion doses of vaccines. Out of this staggering figure, more than 600 million doses were dedicated to export markets. This level of production not only establishes VNIITZH as a leader in veterinary pharmaceuticals but also contributes significantly to Russia’s agricultural exports.
The range of vaccines produced by VNIITZH extends beyond just poultry and swine. Their extensive portfolio includes products designed specifically for the prevention of diseases affecting various species, including large and small cattle as well as wild and domestic animals. This comprehensive approach ensures that VNIITZH can meet the diverse needs of animal health across multiple regions and species.
As global trade in veterinary services continues to evolve, VNIITZH’s efforts are likely to expand even further. The organization’s ongoing commitment to research and development allows it to innovate new immunobiological products to combat emerging diseases that threaten animal populations.
The reaffirmation of VNIITZH's capacity to produce and export high-quality vaccines is vital for addressing animal health challenges worldwide. With the threat of disease constantly looming over livestock and poultry, the role of effective vaccines becomes ever more critical.
Moreover, the trust shown by countries in receiving these vaccines illustrates the importance of international cooperation in the field of animal health. As the number of countries engaging with VNIITZH grows, it sets a precedent for the importance of scientific collaboration across borders, paving the way for improved health standards globally.
Looking ahead, VNIITZH plans to enhance its production capabilities even further, ensuring that it can respond to both domestic and international demands for animal health products. With ongoing investments in technology and facilities, the organization aims to maintain its leading role in ensuring the safety and health of animals worldwide.
In summary, VNIITZH’s achievement of exporting over 224 million doses of vaccines underscores not only the organization's commitment to animal health but also its significant role as a key player in the global veterinary market. The center's dedication to quality and efficacy presents a promising future for both animal agriculture and public health as they continue to navigate the complex challenges of animal disease management.
